Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma

Vollenhoven, 1990, Clinical predictors for buserelin acetate treatment of uterine fibroid: a prospective study of 40 women, Fertil Steril, 54, 1032, 10.1016/S0015-0282(16)54001-1

Filicori, 1983, A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue, Am J Obstet Gynecol, 147, 726, 10.1016/0002-9378(83)90463-5

Uemura, 1989, Shrinkage of uterine leiomyomas after intranasal administration of an LHRH agonist, Nippon Sanka Fujinka Gakkai Zasshi, 41, 365

Nakamura, 1990, Treatment of leiomyomas with luteinizing hormone-releasing hormone agonist, Nippon Sanka Fujinka Gakkai Zasshi, 42, 1620

Morita, 1991, Effect of buserelin presurgical treatment on vascularity in the sub-serosal interstitial tissue of the uterus and operative blood loss at hysterectomy in women with uterine leiomyoma and adenomyosis, Nippon Sanka Fujinka Gakkai Zasshi, 43, 197

Kleinman, 1994, Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: role of apoptosis, Am J Obstet Gynecol, 170, 96, 10.1016/S0002-9378(94)70391-4

Maheux, 1987, Luteinizing hormone-releasing hormone agonist in uterine leiomyomas, Fertil Steril, 47, 229, 10.1016/S0015-0282(16)49996-6

Andreyko, 1998, Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: Assessment by magnetic resonance imaging, Am J Obstet Gynecol, 158, 903, 10.1016/0002-9378(88)90092-0

Gavrieli, 1992, Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, J Cell Biol, 119, 493, 10.1083/jcb.119.3.493

Uemura, 1991, Treatment effects of GnRH agonist on the binding of estrogen and progesterone, and the histological findings of uterine leiomyomas, Asia-Oceania J Obstet Gynaecol, 17, 315, 10.1111/j.1447-0756.1991.tb00280.x

Updahyaya, 1990, Histopathological changes in leiomyomata treated with leuprolide acetate, Fertil Steril, 54, 811, 10.1016/S0015-0282(16)53937-5

Wiznitzer, 1988, Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata, Biochem Biophys Res Commun, 152, 1326, 10.1016/S0006-291X(88)80430-3

Kerr, 1972, Apoptosis: basic biological phenomenon with wide-ranging implications in tissue kinetics, Br J Cancer, 26, 239, 10.1038/bjc.1972.33

Wyllie, 1982, Hormone-induced cell death: Purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment, Am J Pathol, 109, 78

McConkey, 1989, Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration, Arch Biochem Biophys, 269, 365, 10.1016/0003-9861(89)90119-7

Wyllie, 1980, Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation, Nature, 248, 555, 10.1038/284555a0

Morris, 1984, Hormone-induced cell death, Am J Pathol, 115, 426

Fesus, 1987, Induction and activation of tissue transglutaminase during programmed cell death, FEBS Lett, 224, 104, 10.1016/0014-5793(87)80430-1

Fesus, 1989, Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action, FEBS Lett, 245, 150, 10.1016/0014-5793(89)80210-8

Hiraishi, 1993, Ley-antigen expression is correlated with apoptosis (programmed cell death), Glycobiology, 3, 381, 10.1093/glycob/3.4.381

Wyllie, 1980, Cell death: the significance of apoptosis, Int Rev Cytol, 68, 251, 10.1016/S0074-7696(08)62312-8